Roth Trades Stop-Loss For 80/20 Split: Appears Unattractive To Drug Industry
Executive Summary
Finance Committee Chairman Roth's initial approach to catastrophic coverage in a Medicare drug benefit differs substantially from the other major proposals pending on Capitol Hill.
You may also be interested in...
PhRMA/BIO Get "Innovation" And "Modern Medicare" Into GOP Rhetoric
Sen. Frist (R-Tenn.) spotlighted "innovation" as the updated GOP theme for protecting the drug industry against anticipated attacks from the Gore campaign during an Aug. 3 speech to the Republican National Convention in Philadelphia.
PhRMA/BIO Get "Innovation" And "Modern Medicare" Into GOP Rhetoric
Sen. Frist (R-Tenn.) spotlighted "innovation" as the updated GOP theme for protecting the drug industry against anticipated attacks from the Gore campaign during an Aug. 3 speech to the Republican National Convention in Philadelphia.
Medicare Rx Mark-Up By Senate Finance Delayed Until After Recess
The Senate Finance Committee will not mark up Medicare reform legislation that would establish a prescription drug benefit until after the August congressional recess.